Former Religare CMD Sunil Godhwani's bail plea rejected by court

Published On 2020-05-19 12:30 GMT   |   Update On 2020-05-19 12:29 GMT

NEW DELHI -  A Delhi Court has rejected the bail plea of former CMD of Religare Enterprises Limited (REL), Sunil Godhwani, accused of money laundering in a case related to misappropriating funds of Religare Finvest Ltd (RFL).

Additional Sessions Judge Vipin Kumar Rai dismissed Godhwani's bail application.

Read Also:  Private Hospital Defamation Suit: Court directs news channel to publish version of hospital within two days

Godhwani had sought bail on the ground that he was suffering from sleep apnea, a medical condition in which breathing repeatedly stops and starts during sleep. Citing COVID-19, the accused said that his disorder may have serious consequences.

However, the ED's special public prosecutor Nitesh Rana opposed the bail plea, stating that sleep apnea was not a serious medical problem and the jail authorities were taking care of issues due to coronavirus threat.

Advertisement

Enforcement Directorate (ED) on Janaury filed charge sheet against former Fortis Healthcare promoter Malvinder Mohan Singh, Shivinder Singh and former CMD of Religare Enterprises Limited Sunil Godhwani in a money laundering case related to alleged misappropriation of funds at Religare Finvest Limited.

Read Also:  No Relief for Malvinder Singh: Delhi HC dismisses bail plea on COVID19 ground


Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News